[go: up one dir, main page]

Feng et al., 2007 - Google Patents

Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1

Feng et al., 2007

Document ID
6097426268788456669
Author
Feng W
Huang S
Wu H
Zhang M
Publication year
Publication venue
Journal of molecular biology

External Links

Snippet

Beclin-1, originally identified as a Bcl-2 binding protein, is an evolutionarily conserved protein required for autophagy. The direct interaction between Beclin-1 and Bcl-2 or Bcl-xL provides a potential convergence point for apoptosis and autophagy, two programmed cell …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin

Similar Documents

Publication Publication Date Title
Feng et al. Molecular basis of Bcl-xL’s target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1
Day et al. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1
Sun et al. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP
Wang et al. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53
Sattler et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis
Huang et al. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus
Petros et al. Solution structure of the antiapoptotic protein bcl-2
Day et al. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands
Suzuki et al. Structure of Bax: coregulation of dimer formation and intracellular localization
Ogura et al. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide
Huang et al. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2
Vise et al. NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain
Kvansakul et al. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak
Day et al. Localization of dynein light chains 1 and 2 and their pro-apoptotic ligands
Manon et al. Solution structure of NOD1 CARD and mutational analysis of its interaction with the CARD of downstream kinase RICK
US20090118135A1 (en) Methods and compounds for regulating apoptosis
Lee et al. The affinity of Ets-1 for DNA is modulated by phosphorylation through transient interactions of an unstructured region
Sukits et al. Solution structure of the tumor necrosis factor receptor-1 death domain
Coyne III et al. Autoinhibition of ETV6 (TEL) DNA binding: appended helices sterically block the ETS domain
Pierce et al. Is the prion domain of soluble Ure2p unstructured?
Upadhyay et al. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi
Liu et al. High-quality NMR structure of human anti-apoptotic protein domain Mcl-1 (171-327) for cancer drug design
Ultsch et al. Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif
Kieken et al. EH domain of EHD1
Uegaki et al. Structure of the CAD domain of caspase-activated DNase and interaction with the CAD domain of its inhibitor